Cite
Disseminated tumor cells in bone marrow assessed by TWIST1, cytokeratin 19, and mammaglobin A mRNA predict clinical outcome in operable breast cancer patients.
MLA
Tjensvoll, Kjersti, et al. “Disseminated Tumor Cells in Bone Marrow Assessed by TWIST1, Cytokeratin 19, and Mammaglobin A MRNA Predict Clinical Outcome in Operable Breast Cancer Patients.” Clinical Breast Cancer, vol. 10, no. 5, Oct. 2010, pp. 378–84. EBSCOhost, https://doi.org/10.3816/CBC.2010.n.050.
APA
Tjensvoll, K., Oltedal, S., Farmen, R. K., Shammas, F. V., Heikkilä, R., Kvaløy, J. T., Gilje, B., Smaaland, R., & Nordgård, O. (2010). Disseminated tumor cells in bone marrow assessed by TWIST1, cytokeratin 19, and mammaglobin A mRNA predict clinical outcome in operable breast cancer patients. Clinical Breast Cancer, 10(5), 378–384. https://doi.org/10.3816/CBC.2010.n.050
Chicago
Tjensvoll, Kjersti, Satu Oltedal, Ragne K Farmen, Fuad V Shammas, Reino Heikkilä, Jan T Kvaløy, Bjørnar Gilje, Rune Smaaland, and Oddmund Nordgård. 2010. “Disseminated Tumor Cells in Bone Marrow Assessed by TWIST1, Cytokeratin 19, and Mammaglobin A MRNA Predict Clinical Outcome in Operable Breast Cancer Patients.” Clinical Breast Cancer 10 (5): 378–84. doi:10.3816/CBC.2010.n.050.